Compare AANJANEYA LIFECARE with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DISHMAN PHARMA DR. DATSONS LABS/
DISHMAN PHARMA
 
P/E (TTM) x -10.9 25.1 - View Chart
P/BV x 0.2 3.3 4.9% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   DISHMAN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DISHMAN PHARMA
Mar-16
DR. DATSONS LABS/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs126374 33.5%   
Low Rs31129 24.0%   
Sales per share (Unadj.) Rs133.0197.8 67.2%  
Earnings per share (Unadj.) Rs0.221.2 0.7%  
Cash flow per share (Unadj.) Rs6.634.7 19.0%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8179.9 71.6%  
Shares outstanding (eoy) m31.6680.69 39.2%   
Bonus / Rights / Conversions FCCB--  
Price / Sales ratio x0.61.3 46.2%   
Avg P/E ratio x516.111.9 4,349.2%  
P/CF ratio (eoy) x11.87.2 163.4%  
Price / Book Value ratio x0.61.4 43.4%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m2,47720,306 12.2%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m565,355 1.0%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m4,21115,961 26.4%  
Other income Rs m79265 29.7%   
Total revenues Rs m4,28916,226 26.4%   
Gross profit Rs m5694,103 13.9%  
Depreciation Rs m2041,091 18.7%   
Interest Rs m430944 45.6%   
Profit before tax Rs m132,334 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -163.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6624 1.0%   
Profit after tax Rs m51,711 0.3%  
Gross profit margin %13.525.7 52.5%  
Effective tax rate %48.026.7 179.7%   
Net profit margin %0.110.7 1.1%  
BALANCE SHEET DATA
Current assets Rs m6,85211,018 62.2%   
Current liabilities Rs m6,7119,517 70.5%   
Net working cap to sales %3.39.4 35.6%  
Current ratio x1.01.2 88.2%  
Inventory Days Days161110 145.6%  
Debtors Days Days31835 914.2%  
Net fixed assets Rs m3,67316,304 22.5%   
Share capital Rs m317161 196.2%   
"Free" reserves Rs m3,76112,907 29.1%   
Net worth Rs m4,07814,516 28.1%   
Long term debt Rs m1,6714,189 39.9%   
Total assets Rs m12,63329,805 42.4%  
Interest coverage x1.03.5 29.7%   
Debt to equity ratio x0.40.3 142.0%  
Sales to assets ratio x0.30.5 62.2%   
Return on assets %3.48.9 38.6%  
Return on equity %0.111.8 1.0%  
Return on capital %7.717.5 43.8%  
Exports to sales %22.924.8 92.4%   
Imports to sales %14.33.7 382.6%   
Exports (fob) Rs m9643,956 24.4%   
Imports (cif) Rs m602596 100.9%   
Fx inflow Rs m9644,952 19.5%   
Fx outflow Rs m607697 87.1%   
Net fx Rs m3574,255 8.4%   
CASH FLOW
From Operations Rs m1,3452,786 48.3%  
From Investments Rs m-2,256-1,529 147.5%  
From Financial Activity Rs m-1,200-941 127.5%  
Net Cashflow Rs m-2,111316 -667.1%  

Share Holding

Indian Promoters % 4.5 61.4 7.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 12.7 10.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 22.1 425.8%  
Shareholders   20,807 46,261 45.0%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALKEM LABORATORIES  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  FULFORD INDIA  NEULAND LABS  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Related Views on News

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS